VENTURA, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 14.661
EU - Europa 12.079
AS - Asia 2.747
SA - Sud America 116
AF - Africa 28
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 14
Totale 29.670
Nazione #
US - Stati Uniti d'America 14.580
IT - Italia 4.316
GB - Regno Unito 4.208
SE - Svezia 982
CN - Cina 827
SG - Singapore 824
DE - Germania 635
UA - Ucraina 529
HK - Hong Kong 496
FR - Francia 372
TR - Turchia 293
FI - Finlandia 264
RU - Federazione Russa 200
BG - Bulgaria 169
BR - Brasile 95
IN - India 91
NL - Olanda 78
CA - Canada 71
ID - Indonesia 67
BE - Belgio 64
IE - Irlanda 48
CH - Svizzera 34
PL - Polonia 28
VN - Vietnam 28
LT - Lituania 27
MY - Malesia 26
RO - Romania 26
ES - Italia 21
IR - Iran 21
AU - Australia 19
JP - Giappone 18
CZ - Repubblica Ceca 14
PT - Portogallo 13
EU - Europa 12
NO - Norvegia 12
ZA - Sudafrica 9
KR - Corea 8
AR - Argentina 6
AT - Austria 6
GR - Grecia 6
NZ - Nuova Zelanda 6
PH - Filippine 6
AZ - Azerbaigian 5
MX - Messico 5
TW - Taiwan 5
CL - Cile 4
HR - Croazia 4
MK - Macedonia 4
BD - Bangladesh 3
EC - Ecuador 3
EG - Egitto 3
GT - Guatemala 3
HU - Ungheria 3
IL - Israele 3
IQ - Iraq 3
PE - Perù 3
SM - San Marino 3
TH - Thailandia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CO - Colombia 2
DK - Danimarca 2
DZ - Algeria 2
LB - Libano 2
LK - Sri Lanka 2
MA - Marocco 2
MD - Moldavia 2
MT - Malta 2
MU - Mauritius 2
NG - Nigeria 2
RE - Reunion 2
SI - Slovenia 2
ZW - Zimbabwe 2
AL - Albania 1
BN - Brunei Darussalam 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NP - Nepal 1
PK - Pakistan 1
QA - Qatar 1
SA - Arabia Saudita 1
SC - Seychelles 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 29.670
Città #
Southend 3.859
Santa Clara 1.825
Fairfield 1.790
Chandler 1.194
Woodbridge 1.107
Houston 1.062
Ashburn 984
Jacksonville 814
Singapore 623
Ann Arbor 621
Seattle 594
Wilmington 579
Dearborn 574
Cambridge 568
Nyköping 555
Hong Kong 489
Rome 300
Beijing 266
Modena 225
Milan 206
Izmir 194
San Diego 186
Princeton 181
Sofia 165
Eugene 150
Helsinki 140
Bremen 89
New York 77
Des Moines 75
Bologna 67
Moscow 66
Jakarta 65
Parma 65
Rimini 64
London 60
Chicago 58
Brussels 57
Palermo 56
Naples 54
Shanghai 54
Redwood City 53
Falls Church 49
Munich 49
Verona 49
Fremont 37
Florence 33
Bari 31
Hefei 31
Toronto 31
Dublin 30
Catania 29
Padova 28
Phoenix 28
Turin 27
Los Angeles 25
Boardman 24
Dong Ket 24
Norwalk 24
Reggio Emilia 24
San Mateo 24
Kunming 22
Messina 22
Napoli 20
Guangzhou 19
Acton 18
Borzano 18
Nanjing 17
Ottawa 17
Torino 17
Formigine 16
Genoa 15
Mumbai 15
Philadelphia 15
Bergamo 14
Brescia 14
Paris 14
Amsterdam 13
Andover 13
Dallas 13
Kilburn 13
Pisa 12
San Giuliano Milanese 12
Brno 11
Como 11
Genova 11
Prescot 11
Augusta 10
Cagliari 10
Jinan 10
Reggio Nell'emilia 10
Trieste 10
Belo Horizonte 9
Birmingham 9
Chiswick 9
Hounslow 9
Nanchang 9
Perugia 9
Pescara 9
Ravenna 9
Siena 9
Totale 21.332
Nome #
Effetti dell’insulina sui livelli di omocisteina plasmatica in pazienti con diabete mellito tipo ii con e senza intolleranza alla metionina 1.978
Weight Loss Expectations in Obese Patients and Treatment Attrition: An Observational Multicenter Study 612
Validating the Body Uneasiness Test (BUT) in obese patients 547
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 514
Trombosi portale e iperomocisteinemia in pazienti con cirrosi epatica 436
Isomeri urinari della Coproporfirina in pazienti con Epatopatie Colestatiche Acquisite e sindrome di Dubin-Johnson 436
Impiego dei marcatori di neoplasia (CEA, CA 19.9, CA 125, CA 16.3, NSE) in Medinina Interna: uno studio retrospettivo 428
The QUOVADIS Study: features of obese Italian patients seeking treatment at specialist centers 422
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks 308
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 291
The Acute Porphyric Attack: A Difficult Diagnosis for a Potential Lethal Event in Emergency Medicine 284
Oxford Manuale di Medicina Clinica 282
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 280
Weight Loss Expectations in Obese Patients Seeking Treatment at Medical Centers 268
Acute Intermittent Porphyria in a Child with Severe Neuropathy 252
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 241
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 240
Drugs and acute porphyrias: reasons for a hazardous relationship 238
A challenging diagnosis for potential fatal diseases: Recommendations for diagnosing acute porphyrias 237
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? 234
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 229
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 222
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 220
Weight cycling in treatment-seeking obese persons: data from the QUOVADIS study 220
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS. 219
Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics 217
Safety and efficacy of sucrosomal iron in inflammatory bowel disease patients with iron deficiency anemia 215
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 212
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 211
HYPERHOMOCYSTEINEMIA AND MTHFR C677T POLYMORPHISM IN PATIENTS WITH PORTAL VEIN THROMBOSIS COMPLICATING LIVER CIRRHOSIS 210
Psychological Distress in Morbid Obesity in Relation to Weight History 208
Tumour markers in internal medicine: a low-cost test or an unnecessary expense? A retrospective study based on appropriateness 208
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 204
Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians 202
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 196
THE INTERACTION OF BILIAR ACIDS WITH 2-HYDROXYPROPYL-CYCLODEXTRIN IN SOLUTION AND IN THE SOLID STATE 193
The Metabolic Syndrome in Treatment-Seeking Obese Persons 192
Snoring, hypertension and Type 2 diabetes in obesity. Protection by physical activity 191
HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCCAND LIVER CIRRHOSIS 189
Studi preformulativi sul complesso di inclusione tra acido ursodesossicolico e beta-ciclodestrine 189
Anti- and pro-oxidant factors and endothelial dysfunction in chronic cigarette smokers with coronary heart disease 189
When awareness makes the difference: diagnosing and treating the acute hepatic porphyrias 188
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome 187
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 185
A role for homocysteine increase in haemolysis of megaloblastic anaemias due to vitamin B-12 and folate deficiency: results from an in vitro experience 184
The Effect of Obesity Management on Body Image in Patients Seeking Treatment at Medical Centers 184
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy 183
Hepatocellular Carcinoma in HIV-infected Patients: Check Ealy, Treat Hard 183
A large deletion on chromosome 11 in acute intermittent porphyria 182
Construct Validity of the Short Form-36 Health Survey and Its Relationship with BMI in Obese Outpatients 181
Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus. 181
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 180
Red wine consumption prevents vascular oxidative stress induced by a high-fat meal in healthy volunteers 179
Molecular characterization, by digital PCR analysis of four HMBS gene mutations affecting the ubiquitous isoform of Porphobilinogen Deaminase (PBGD) in patients with Acute Intermittent Porphyria (AIP) 179
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 178
Prevention of a first episode of variceal bleeding: role of duplex Doppler sonographic measurement of the acute response to beta-blockers. 176
EXPLORE: A prospective, multinational natural history study of acute hepatic porphyria patients with recurrent attacks 176
N-acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion 175
Urinary coproporhyrin isomers during therapy with IFn-RIBA in patients with chronic hepatitis due to HCV infection 174
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 173
Pro-oxidant and antioxidant factors in acute intermittent porphyria: Family studies 171
Clinical and psychological correlates of health related quality of life in obese patients 169
Portal vein thrombosis relevance on liver cirrhosis: Italina Venous Thrombotic Events Registry 169
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 169
Weight management, psychological distress and binge eating in obesity. A reappraisal of the problem 168
Impact of nutrition on cognition and affectivity in the elderly: A review 166
Role of Multidrug-Resistance Protein 2 in coproporphyrin transport: results from experimental studies in bile fistula rat models 166
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 166
Porfiria acuta intermittente: un caso "eccezionale" 165
Relevance of different apolipoprotein content in binding of homocysteine to plasma lipoproteins 163
Hepatocellular carcinoma in HIV infected patients: check early, treat hard. 163
Weight loss and clinical characteristics of young adults patients seeking treatment at medical centers: Data from the QUOVADIS Study 162
Personality features of obese women in relation to binge eating and night eating 160
Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects 159
Clinical, biochemical and genetic characteristics of Variegate Porphyria in Italy 159
Metabolic syndrome, psychological status and quality of life in obesity: the QUOVADIS Study 159
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 159
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 155
Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine oral loading 154
Radiofrequency ablation combined with transcatheter arterial chemioembolization in the treatment of advanced hepatocellular carcinoma 154
CLINICAL OUTCOMES AND SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND HIV INFECTION 154
Affinità dell'omocisteina per le lipoproteine 153
Serum endothelin-1 as predictor of ascitic decompensation in patients with liver cirrhosis 152
Does the measurement of portal flow velocity have any value in the identification of patients with cirrhosis at risk of digestive bleeding ? 150
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 149
Novel human pathological mutations. Gene symbol: PPOX. Disease: porphyria, variegate 148
Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis 147
Distribution of homocysteine in plasma lipoproteins 147
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 147
Interindividual variability of the number connection test 145
Correlation between plasma malonyldialdeide levels and paroxonase activity in healthy subjects and in patients with atherosclerotic disease 145
One- and two-dimensional NMR study of complexation of ursodeoxycholic acid with beta-cyclodextrin 144
Duplex-Doppler ultrasonography in the evaluation of cirrhotic patients with portal hypertension and in the analysis of their response to drugs 144
Sarcoma primitivo del cuore. Descrizione di un caso 143
Duplex-Doppler assessment of cirrhosis in patients with chronic compensated liver disease 143
Improvement of survival in patients with intermediate stage (BCLC-B) hepatocellular acrcinoma complicating liver cirrhosis by combination therapy with radiofrequency ablation and transcatheter chemioembolization 143
Insulin resistance in advanced liver cirrhosis : the role of liver dysfunction and the “dissociated” effect on glucose versus lipid and amino acid metabolism 142
Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats 142
Homocysteine Production and membrane oxidative stress in erythrocytes 139
Efficacy and safety of combination therapy with pegylated interferon and ribavirin in aged patients with chronic hepatitis C 139
Totale 22.464
Categoria #
all - tutte 107.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.132


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.945 0 0 0 0 0 0 1.023 437 541 316 335 293
2020/20215.014 355 277 422 406 646 404 652 458 289 459 347 299
2021/20223.669 178 412 290 308 143 217 211 219 407 316 538 430
2022/20234.119 423 420 318 370 452 551 118 389 491 112 229 246
2023/20242.739 168 179 241 227 399 196 225 336 115 124 192 337
2024/20254.222 322 149 325 583 1.543 1.083 217 0 0 0 0 0
Totale 29.931